Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients.

about

Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients.

Item

http://www.wikidata.org/entity/Q40171742

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Evaluation of the Interaction ...... rine in Iranian HSCT Patients.

@en

type

Item

label

Evaluation of the Interaction ...... rine in Iranian HSCT Patients.

@en

prefLabel

Evaluation of the Interaction ...... rine in Iranian HSCT Patients.

@en

P1476

Evaluation of the Interaction ...... rine in Iranian HSCT Patients.

@en

P2093

Ardeshir Ghavamzadeh

http://www.w3.org/2001/XMLSchema#string

Hamidreza Taghvaye Masoumi

http://www.w3.org/2001/XMLSchema#string

Mohammad Vaezi

http://www.w3.org/2001/XMLSchema#string

Molouk Hadjibabaie

http://www.w3.org/2001/XMLSchema#string

P2860

Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.

Pharmacokinetic/pharmacodynamic profile of voriconazole.

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation.

Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.

Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring.

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.

Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.

Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy.

P304

77-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/JRPP.JRPP_16_163

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28616429

http://www.w3.org/2001/XMLSchema#string

P932

5463553

http://www.w3.org/2001/XMLSchema#string